Yossi Maimon

2010 - Protalix BioTherapeutics

In 2010, Yossi Maimon earned a total compensation of $419.5K as Vice President, Chief Financial Officer at Protalix BioTherapeutics, a 35% decrease compared to previous year.

Compensation breakdown

Bonus$20,000
Option Awards$63,175
Salary$268,154
Other$68,156
Total$419,485

Maimon received $268.2K in salary, accounting for 64% of the total pay in 2010.

Maimon also received $20K in bonus, $63.2K in option awards and $68.2K in other compensation.

Rankings

In 2010, Yossi Maimon's compensation ranked 8,263rd out of 10,439 executives tracked by ExecPay. In other words, Maimon earned more than 20.8% of executives.

ClassificationRankingPercentile
All
8,263
out of 10,439
21st
Division
Manufacturing
3,078
out of 3,838
20th
Major group
Chemicals And Allied Products
738
out of 921
20th
Industry group
Drugs
521
out of 680
23rd
Industry
Biological Products, Except Diagnostic Substances
106
out of 142
25th
Source: SEC filing on September 19, 2013.

Maimon's colleagues

We found five more compensation records of executives who worked with Yossi Maimon at Protalix BioTherapeutics in 2010.

2010

David Aviezer

Protalix BioTherapeutics

Chief Executive Officer

2010

Sandra Lauterbach

Protalix BioTherapeutics

Vice President, Sales and Commercial Affairs

2010

Yoseph Shaaltiel

Protalix BioTherapeutics

Executive Vice President, Research and Development

2010

Einat Almon

Protalix BioTherapeutics

Senior Vice President, Product Development

2010

Tzvi Palash

Protalix BioTherapeutics

Chief Operating Officer

News

You may also like